SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-16-022567
Filing Date
2016-04-01
Accepted
2016-04-01 17:30:11
Documents
2
Period of Report
2016-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 1660
2 ex-24truex.txt EX-24.TXT 3464
  Complete submission text file 0001179110-16-022567.txt   6685
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Issuer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PENINSULA PHARMACEUTICALS, INC. 1751 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address
TRUEX PAUL F (Reporting) CIK: 0001120362 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36500 | Film No.: 161548297